Stephen Kilmer - Intelgenx Technologs Investor Officer

IGXT Stock

USD 0.17 0.00 0.00%

Insider

Stephen Kilmer is Investor Officer of Intelgenx Technologs

Phone	514 331 7440
Web	https://www.intelgenx.com

Intelgenx Technologs Management Efficiency

The company has return on total asset (ROA) of (0.367) % which means that it has lost $0.367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.2896) %, meaning that it created substantial loss on money invested by shareholders. Intelgenx Technologs' management efficiency ratios could be used to measure how well Intelgenx Technologs manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Intelgenx Technologs to Peers

Predict price of Intelgenx Technologs

Intelgenx Technologs currently holds 6.21 M in liabilities with Debt to Equity (D/E) ratio of 6.42, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intelgenx Technologs has a current ratio of 3.55, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Intelgenx Technologs until it has trouble settling it off, either with new capital or with free cash flow. So, Intelgenx Technologs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intelgenx Technologs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intelgenx to invest in growth at high rates of return. When we think about Intelgenx Technologs' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Terence Kohler	Verrica Pharmaceuticals	N/A
	Lei Sun	Connect Biopharma Holdings	60
	MBA MD	Monopar Therapeutics	38
	Kathryn Falberg	Nuvation Bio	60
	Eric MD	Acumen Pharmaceuticals	69
	Raul Collazo	Connect Biopharma Holdings	N/A
	Liean MS	Acumen Pharmaceuticals	N/A
	Robert DeLuccia	Acurx Pharmaceuticals LLC	78
	John MBA	Ascletis Pharma	N/A
	Daniel Welch	Nuvation Bio	63
	Winston MBA	Pmv Pharmaceuticals	48
	David Hanley	Nuvation Bio	54
	Jinzi Wu	Ascletis Pharma	60
	James CPA	Eton Pharmaceuticals	52
	Siew MS	Acumen Pharmaceuticals	N/A
	Mark Meier	Fennec Pharmaceuticals	N/A
	Gary Hattersley	Nuvation Bio	57
	Seshu Tyagarajan	Candel Therapeutics	56
	Thomas Templeman	Nuvation Bio	60
	Kim Blickenstaff	Nuvation Bio	68
	Francis Conway	Larimar Therapeutics	N/A

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada. Intelgenx Technologs operates under Biotechnology classification in the United States and is traded on OTC Exchange. Intelgenx Technologs [IGXT] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

	Return On Equity	-5.29
	Return On Asset	-0.37

Intelgenx Technologs Leadership Team

Elected by the shareholders, the Intelgenx Technologs' board of directors comprises two types of representatives: Intelgenx Technologs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelgenx. The board's role is to monitor Intelgenx Technologs' management team and ensure that shareholders' interests are well served. Intelgenx Technologs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelgenx Technologs' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Stephen Kilmer, Investor Officer
	JD LLB, VP Counsel
	Ingrid Zerbe, Director - Finance and Administration, Corporate Secretary
	Nadine Paiement, Vice President - Research & Development
	Horst Zerbe, Founder, Chairman, CEO and Pres

Intelgenx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Intelgenx Technologs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-5.29
	Return On Asset	-0.37
	Operating Margin	(7.39) %
	Current Valuation	30.97 M
	Shares Outstanding	174.65 M
	Shares Owned By Insiders	22.64 %
	Price To Earning	(55.38) X
	Price To Book	11.54 X
	Price To Sales	19.11 X
	Revenue	1.53 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelgenx Pink Sheet Analysis

When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC